Expression of the antiapoptosis gene survivin in human leukemia

International Journal of Hematology

Volumn 75, Issue 2, 2002, Pages 161-165

  Mori, Ako ^a,b   Wada, Hiroshi ^a   Nishimura, Yasuo ^a   Okamoto, Takahiro ^a   Takemoto, Yoshinobu ^a   Kakishita, Eizo ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b TAKARAZUKA CITY HOSPITAL   (Japan)

Author keywords

Acute lymphocytic leukemia; Acute myelocytic leukemia; Chronic myelocytic leukemia; Differentiation; Survivin

Indexed keywords

DIMETHYL SULFOXIDE; RETINOIC ACID; SURVIVIN; BIRC5 PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; TUMOR PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CHRONIC MYELOID LEUKEMIA; DOWN REGULATION; DRUG INHIBITION; DRUG MECHANISM; GENE EXPRESSION; HEMATOPOIETIC CELL; HUMAN; LEUKEMIA; PATHOGENESIS; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ACUTE DISEASE; CELL CULTURE; DISEASE FREE SURVIVAL; METABOLISM; MORTALITY; MYELOID LEUKEMIA; PROSPECTIVE STUDY;

ACUTE DISEASE; CELL DIFFERENTIATION; DISEASE-FREE SURVIVAL; HUMANS; LEUKEMIA, MYELOID; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; PROSPECTIVE STUDIES; TUMOR CELLS, CULTURED;

EID: 85047693509     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02982021     Document Type: Article

References (15)

1. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995;267:1456-1462.
2. LaCasse EC, Baird S, Korneluk RG, MacKenzie AE. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene. 1998;17:3247-3259.
3. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 1997;3:917-921.
4. Adida C, Berrebi D, Peuchmaur M, Reyes-Mugica M, Altieri DC. Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet. 1998;351:882-883.
5. Islam A, Kageyama H, Takada N, et al. High expression of survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene. 2000;19:617-623.
6. Wada H, Mizutani S, Nishimura J, et al. Establishment and molecular characterization of a novel leukemic cell line with Philadelphia chromosome expressing p230 BCR/ABL fusion protein. Cancer Res. 1995;55:3192-3196.
7. Israeli RS, Miller WH Jr, Su SL, et al. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res. 1994;54:6306-6310.
8. Gerhardt TM, Schmahl GE, Flotho C, Rath AV, Niemeyer CM. Expression of the Evi-1 gene in haemopoietic cells of children with juvenile myelomonocytic leukemia and normal donors. Br J Haematol. 1997;99:882-887.
9. Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA, El-Houseini ME. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene. 1994;9:3389-3396.
10. Lu CD, Altieri DC, Tanigawa N. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res. 1998;58:1808-1812.
11. Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjyo T, Tanigawa N. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res. 1998;58:5071-5074.
12. Monzo M, Rosell R, Felip E, et al. A novel anti-apoptosis gene: reexpression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J Clin Oncol. 1999;17:2100-2104.
13. Li F, Ambrosini G, Chu EY, et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature. 1998;396:580-584.
14. Tamm I, Wang Y, Sausville E, et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res. 1998;58:5315-5320.
15. Estrov Z, Thall PF, Talpaz M, et al. Caspase 2 and caspase 3 protein levels as predictors of survival in acute myelogenous leukemia. Blood. 1998;92:3090-3097.